| CURLF Stock | | | USD 1.95 0.04 2.01% |
Insider
Jakob Feinstein is Ma Relations of Curaleaf Holdings
| Phone | 781 451 0159 |
| Web | https://www.curaleaf.com |
Curaleaf Holdings Management Efficiency
The company has return on total asset
(ROA) of
0.0226 % which means that it generated a profit of $0.0226 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.0776) %, meaning that it generated substantial loss on money invested by shareholders. Curaleaf Holdings' management efficiency ratios could be used to measure how well Curaleaf Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
Curaleaf Holdings has accumulated 434.12
M in total debt with debt to equity ratio
(D/E) of 0.56, which is about average as compared to similar companies. Curaleaf Holdings has a current ratio of 2.39, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Curaleaf Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Curaleaf Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Curaleaf Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Curaleaf to invest in growth at high rates of return. When we think about Curaleaf Holdings' use of debt, we should always consider it together with cash and equity.
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts. Curaleaf Holdings operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5600 people. Curaleaf Holdings [CURLF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.
Management Performance
Curaleaf Holdings Leadership Team
Elected by the shareholders, the Curaleaf Holdings' board of directors comprises two types of representatives: Curaleaf Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Curaleaf. The board's role is to monitor Curaleaf Holdings' management team and ensure that shareholders' interests are well served. Curaleaf Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Curaleaf Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Camilo Lyon, Chief Officer | |
| Edward Kremer, Chief Officer | |
| Matthew Darin, Chief Officer | |
| James Shorris, Chief Officer | |
| Joseph Lusardi, President CEO, Director | |
| Joseph Bayern, Exec Markets | |
| Boris Jordan, Executive Chairman of the Board | |
| Peter JD, Chief Officer | |
| Joe Holland, Ex Operations | |
| Jakob Feinstein, Ma Relations | |
Curaleaf Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Curaleaf Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Curaleaf OTC Stock
Curaleaf Holdings financial ratios help investors to determine whether Curaleaf OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Curaleaf with respect to the benefits of owning Curaleaf Holdings security.